NM_000075.4(CDK4):c.132_143dup (p.Gly45_Gly48dup) AND Hereditary melanoma

Clinical significance:Uncertain significance (Last evaluated: Jun 17, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001047782.2

Allele description [Variation Report for NM_000075.4(CDK4):c.132_143dup (p.Gly45_Gly48dup)]

NM_000075.4(CDK4):c.132_143dup (p.Gly45_Gly48dup)

Gene:
CDK4:cyclin dependent kinase 4 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
12q14.1
Genomic location:
Preferred name:
NM_000075.4(CDK4):c.132_143dup (p.Gly45_Gly48dup)
HGVS:
  • NC_000012.12:g.57751584_57751595dup
  • NG_007484.2:g.5796_5807dup
  • NM_000075.4:c.132_143dupMANE SELECT
  • NP_000066.1:p.Gly45_Gly48dup
  • LRG_490:g.5796_5807dup
  • NC_000012.11:g.58145357_58145358insCCTCCTCCACCT
  • NC_000012.11:g.58145367_58145378dup
  • NM_000075.3:c.132_143dup
Links:
Molecular consequence:
  • NM_000075.4:c.132_143dup - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Name:
Hereditary melanoma
Synonyms:
Hereditary cutaneous melanoma; Familial melanoma
Identifiers:
MONDO: MONDO:0018961; MedGen: C1512419

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001211762Invitaecriteria provided, single submitter
Uncertain significance
(Jun 17, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001211762.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant, c.132_143dup, results in the insertion of 4 amino acid(s) to the CDK4 protein (p.Gly45_Gly48dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CDK4-related conditions. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2021

Support Center